Related Experiment Videos
The Mammography Quality Standards Act and interventional mammography procedures
Bulletin of the American College of Surgeons
|March 1, 1997
Summary
The Food and Drug Administration (FDA) is developing new regulations for mammographic interventional procedures. These rules aim to ensure high-quality breast cancer diagnosis services by collaborating with professional groups.
Area of Science:
- Medical Imaging
- Regulatory Science
Background:
- Mammographic interventional procedures are crucial for breast cancer diagnosis.
- Current practices may be affected by upcoming regulatory changes.
Purpose of the Study:
- To inform stakeholders about the FDA's development of mammography regulations.
- To highlight the collaborative approach in shaping these new standards.
Main Methods:
- The FDA is engaging in early-stage regulatory development.
- Collaboration includes professional organizations like the American College of Surgeons (ACS) and American College of Radiology (ACR).
Main Results:
- Regulations are in the early development phase.
- Stakeholder input is being actively sought.
Conclusions:
- The forthcoming regulations are expected to significantly influence mammographic interventional procedures.
- The ultimate goal is to maintain and improve access to high-quality breast cancer diagnostic services.